WallStreetZenWallStreetZen

NASDAQ: BCTX
Briacell Therapeutics Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BCTX

Based on 1 analyst offering 12 month price targets for Briacell Therapeutics Corp

Min Forecast
$40.00+345.68%
Avg Forecast
$40.00+345.68%
Max Forecast
$40.00+345.68%

Should I buy or sell BCTX stock?

Based on 1 analyst offering ratings for Briacell Therapeutics Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BCTX's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates BCTX as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their BCTX stock forecasts and price targets.

BCTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-08-27

1 of 1

Forecast return on equity

Is BCTX forecast to generate an efficient return?

Company
-31.74%
Industry
251.16%
Market
229.15%
BCTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BCTX forecast to generate an efficient return on assets?

Company
-22.7%
Industry
89.79%
BCTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BCTX earnings per share forecast

What is BCTX's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$11.56
Avg 2 year Forecast
-$3.43
Avg 3 year Forecast
-$1.58

BCTX revenue forecast

What is BCTX's revenue in the next 2 years based on estimates from 2 analysts?

Avg 1 year Forecast
$2.1M
Avg 2 year Forecast
$10.2M

BCTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BCTX$8.98$40.00+345.68%Buy
HOTH$1.09$5.00+358.72%Strong Buy
APLT$0.12$1.00+754.70%Hold
ALLR$1.06$9.50+796.23%Buy
BLRX$3.18$26.00+717.61%Buy
View Top Biotech Stocks

Briacell Therapeutics Stock Forecast FAQ

Is Briacell Therapeutics Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BCTX) stock is to Buy BCTX stock.

Out of 1 analyst, 0 (0%) are recommending BCTX as a Strong Buy, 1 (100%) are recommending BCTX as a Buy, 0 (0%) are recommending BCTX as a Hold, 0 (0%) are recommending BCTX as a Sell, and 0 (0%) are recommending BCTX as a Strong Sell.

If you're new to stock investing, here's how to buy Briacell Therapeutics stock.

What is BCTX's earnings growth forecast for 2026-2028?

(NASDAQ: BCTX) Briacell Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.57%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.92%.

Briacell Therapeutics's earnings in 2025 is -$29,078,701.On average, 2 Wall Street analysts forecast BCTX's earnings for 2026 to be -$21,786,431, with the lowest BCTX earnings forecast at -$21,139,309, and the highest BCTX earnings forecast at -$22,649,260. On average, 2 Wall Street analysts forecast BCTX's earnings for 2027 to be -$6,469,333, with the lowest BCTX earnings forecast at -$6,277,175, and the highest BCTX earnings forecast at -$6,725,544.

In 2028, BCTX is forecast to generate -$2,968,282 in earnings, with the lowest earnings forecast at -$2,880,115 and the highest earnings forecast at -$3,085,838.

What is BCTX's revenue growth forecast for 2026-2027?

(NASDAQ: BCTX) Briacell Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 99.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.58%.

Briacell Therapeutics's revenue in 2025 is $0.On average, 2 Wall Street analysts forecast BCTX's revenue for 2026 to be $3,995,765, with the lowest BCTX revenue forecast at $3,877,079, and the highest BCTX revenue forecast at $4,154,013.

In 2027, BCTX is forecast to generate $19,217,725 in revenue, with the lowest revenue forecast at $18,646,902 and the highest revenue forecast at $19,978,823.

What is BCTX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: BCTX) forecast ROA is -22.7%, which is lower than the forecast US Biotechnology industry average of 89.79%.

What is BCTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BCTX price target, the average BCTX price target is $40.00, with the highest BCTX stock price forecast at $40.00 and the lowest BCTX stock price forecast at $40.00.

The Wall Street analyst predicted that Briacell Therapeutics's share price could reach $40.00 by Aug 27, 2026. The average Briacell Therapeutics stock price prediction forecasts a potential upside of 345.68% from the current BCTX share price of $8.98.

What is BCTX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: BCTX) Briacell Therapeutics's current Earnings Per Share (EPS) is -$39.24. On average, analysts forecast that BCTX's EPS will be -$11.56 for 2026, with the lowest EPS forecast at -$11.22, and the highest EPS forecast at -$12.02. On average, analysts forecast that BCTX's EPS will be -$3.43 for 2027, with the lowest EPS forecast at -$3.33, and the highest EPS forecast at -$3.57. In 2028, BCTX's EPS is forecast to hit -$1.58 (min: -$1.53, max: -$1.64).

What is BCTX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: BCTX) forecast ROE is -31.74%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.